Iris Noordhoek

438 total citations
13 papers, 262 citations indexed

About

Iris Noordhoek is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Iris Noordhoek has authored 13 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Iris Noordhoek's work include Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (5 papers) and Estrogen and related hormone effects (4 papers). Iris Noordhoek is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (5 papers) and Estrogen and related hormone effects (4 papers). Iris Noordhoek collaborates with scholars based in Netherlands, United States and France. Iris Noordhoek's co-authors include Marvyn T. Koning, Carmen Vleggeert‐Lankamp, Wilco Jacobs, Gerrit‐Jan Liefers, Hein Putter, Marjolijn Duijm‐de Carpentier, Elma Meershoek‐Klein Kranenbarg, Cornelis J.�H. van de Velde, Kai Treuner and Catherine A. Schnabel and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Iris Noordhoek

13 papers receiving 255 citations

Peers

Countries citing papers authored by Iris Noordhoek

Since Specialization

Citations

This map shows the geographic impact of Iris Noordhoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Noordhoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Noordhoek more than expected).

Fields of papers citing papers by Iris Noordhoek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Noordhoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Noordhoek. The network helps show where Iris Noordhoek may publish in the future.

Co-authorship network of co-authors of Iris Noordhoek

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Noordhoek. A scholar is included among the top collaborators of Iris Noordhoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Noordhoek. Iris Noordhoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial 2022 ·Journal of Clinical Oncology ·S.B. Vliek, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, (unknown), Vincent O. Dezentjé, Agnes Jager, (unknown), Hein Putter, Annette W.G. van der Velden, Mathijs P. Hendriks, Sandra D. Bakker, Yvonne E A van Riet, Vivianne C. G. Tjan‐Heijnen, Johanneke E.A. Portielje, Judith R. Kroep, J.W.R. Nortier, Cornelis J.�H. van de Velde, Sabine C. Linn	8
2	Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer 2022 ·Oncogene ·(unknown), Begüm Kocatürk, Araci M. R. Rondon, (unknown), (unknown), Rob F. P. van den Akker, Daniëlle Krijgsman, Iris Noordhoek, Erik J. Blok, Vladimir Y. Bogdanov, Wolfram Ruf, Peter J.K. Kuppen, Henri H. Versteeg	15
3	Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study 2022 ·Journal of Geriatric Oncology ·Iris Noordhoek, Esther Bastiaannet, (unknown), (unknown), Laura J. Esserman, Jelle Wesseling, Astrid N. Scholten, Carolien P. Schröder, (unknown), Judith R. Kroep, Johanneke E.A. Portielje, Miranda Kleijn, Gerrit‐Jan Liefers	9
4	Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study. 2022 ·Journal of Clinical Oncology ·Gerrit‐Jan Liefers, Iris Noordhoek, Hein Putter, (unknown), (unknown), Yi Zhang, (unknown), Marjolijn Duijm‐de Carpentier, Cornelis J.�H. van de Velde, Catherine A. Schnabel, Kai Treuner	1
5	7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer 2021 ·Annals of Oncology ·Gerrit‐Jan Liefers, Iris Noordhoek, (unknown), Dennis C. Sgroi, Hein Putter, Kai Treuner, Jacqueline Wong, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, CJH van de Velde, Catherine A. Schnabel	2
6	Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry 2021 ·Annals of Surgical Oncology ·Antonio Esgueva, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, Martín Espinosa-Bravo, Zoltán Mátrai, (unknown), Arvīds Irmejs, (unknown), Francesco Meani, (unknown), Murat Özdemir, Tanir M. Allweis, (unknown), Catarina Rodrigues dos Santos, (unknown), Riccardo Ponzone, (unknown), Cornelis J.�H. van de Velde, Riccardo A. Audisio, Isabel T. Rubio, (unknown)	5
7	Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy 2020 ·Clinical Cancer Research ·Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, (unknown), Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, Cornelis J.�H. van de Velde, Catherine A. Schnabel, Gerrit‐Jan Liefers	73
8	Breast cancer index (BCI) predicts benefit of two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the ideal trial. 2020 ·Journal of Clinical Oncology ·Gerrit‐Jan Liefers, Iris Noordhoek, Kai Treuner, Hein Putter, (unknown), (unknown), (unknown), Cornelis J.�H. van de Velde, Catherine A. Schnabel	2
9	Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials 2020 ·Journal of Clinical Oncology ·Iris Noordhoek, Erik J. Blok, Elma Meershoek‐Klein Kranenbarg, Hein Putter, Marjolijn Duijm‐de Carpentier, Emiel J. Rutgers, Caroline Seynaeve, John M.S. Bartlett, Jean-Michel Vannetzel, Daniel Rea, Annette Hasenburg, Robert Paridaens, Christos Markopoulos, Yasuo Hozumi, Johanneke E.A. Portielje, Judith R. Kroep, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	21
10	European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery 2019 ·European Journal of Surgical Oncology ·Serge Évrard, (unknown), Iris Noordhoek, Carmela Caballero, Wim Ceelen, Karol Połom, Agnieszka Kołacińska, William Allum, Domenico D’Ugo, (unknown), (unknown), Lynda Wyld, Marjut Leidenius, Michel Rivoire, Odysseas Zoras, Wojciech Polkowski, (unknown), Riccardo A. Audisio, Tibor Kovács, Santiago González‐Moreno	1
11	Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer 2019 ·Breast Cancer Research and Treatment ·Iris Noordhoek, (unknown), Debbie L. Cohen, Gerrit‐Jan Liefers, Johanneke E.A. Portielje, Judith R. Kroep	12
12	Evaluation of bony fusion after anterior cervical discectomy: a systematic literature review 2018 ·European Spine Journal ·Iris Noordhoek, Marvyn T. Koning, Carmen Vleggeert‐Lankamp	26
13	Incidence and clinical relevance of cage subsidence in anterior cervical discectomy and fusion: a systematic review 2018 ·Acta Neurochirurgica ·Iris Noordhoek, Marvyn T. Koning, Wilco Jacobs, Carmen Vleggeert‐Lankamp	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact